These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 32865669)

  • 1. Prevalence and outcomes of re-positive nucleic acid tests in discharged COVID-19 patients.
    Du HW; Chen JN; Pan XB; Chen XL; Yixian-Zhang ; Fang SF; Li XQ; Xia PC; Gao L; Lin HL; Chen LM; Liu N;
    Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):413-417. PubMed ID: 32865669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics, cause analysis and infectivity of COVID-19 nucleic acid repositive patients: A literature review.
    Li Y; Ji D; Cai W; Hu Y; Bai Y; Wu J; Xu J
    J Med Virol; 2021 Mar; 93(3):1288-1295. PubMed ID: 32890414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of COVID-19 Documented with RT-PCR.
    Ak R; Yilmaz E; Seyhan AU; Doganay F
    J Coll Physicians Surg Pak; 2021 Jan; 31(1):S26-S28. PubMed ID: 33650420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-Detectable Positive RT-PCR Test Results in Recovered COVID-19 Patients: The Potential Role of ACE2.
    Vargas-Ferrer J; Zamora-Mostacero V
    Disaster Med Public Health Prep; 2020 Aug; 14(4):e36-e37. PubMed ID: 32713380
    [No Abstract]   [Full Text] [Related]  

  • 5. Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review.
    Dao TL; Hoang VT; Gautret P
    Eur J Clin Microbiol Infect Dis; 2021 Jan; 40(1):13-25. PubMed ID: 33113040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of "re-positive" discharged COVID-19 pneumonia patients in Wuhan, China.
    He S; Zhou K; Hu M; Liu C; Xie L; Sun S; Sun W; Chen L
    Sci Rep; 2020 Oct; 10(1):17365. PubMed ID: 33060676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature.
    Gidari A; Nofri M; Saccarelli L; Bastianelli S; Sabbatini S; Bozza S; Camilloni B; Fusco-Moffa I; Monari C; De Robertis E; Mencacci A; Francisci D
    Eur J Clin Microbiol Infect Dis; 2021 Jan; 40(1):1-12. PubMed ID: 33037944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia.
    Lancman G; Mascarenhas J; Bar-Natan M
    J Hematol Oncol; 2020 Oct; 13(1):131. PubMed ID: 33008453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and Clinical Findings of Short-Term Recurrence of Severe Acute Respiratory Syndrome Coronavirus 2 Ribonucleic Acid Polymerase Chain Reaction Positivity in 1282 Discharged Coronavirus Disease 2019 Cases: A Multicenter, Retrospective, Observational Study.
    Chen SL; Xu H; Feng HY; Sun JF; Li X; Zhou L; Song WL; Huang SS; He JL; Deng YY; Wang RJ; Fang M
    Open Forum Infect Dis; 2020 Oct; 7(10):ofaa432. PubMed ID: 33123610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and meta-analysis of factors associated with re-positive viral RNA after recovery from COVID-19.
    Hoang T
    J Med Virol; 2021 Apr; 93(4):2234-2242. PubMed ID: 33135788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study.
    Zheng J; Zhou R; Chen F; Tang G; Wu K; Li F; Liu H; Lu J; Zhou J; Yang Z; Yuan Y; Lei C; Wu X
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008648. PubMed ID: 32866168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of SARS-CoV-2 after Asymptomatic Infection while on High-Dose Corticosteroids. Case Report.
    Patrocínio de Jesus R; Silva R; Aliyeva E; Lopes L; Portugalyan M; Antunes L; Diaz P; Costa C; Araújo AC; Coelho S; Mendes JJ; Gomes S; Serra I; Freitas P
    SN Compr Clin Med; 2020; 2(11):2402-2405. PubMed ID: 33043249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late Reactivation of SARS-CoV-2: A Case Report.
    Coppola A; Annunziata A; Carannante N; Di Spirito V; Fiorentino G
    Front Med (Lausanne); 2020; 7():531. PubMed ID: 32974374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance and re-positive RNA test in patients recovered from COVID-19.
    Hu J; Li S; Wu Y; Xiong Z; Yang Y; Gong L; Tian F
    J Med Virol; 2021 Mar; 93(3):1221-1224. PubMed ID: 32990948
    [No Abstract]   [Full Text] [Related]  

  • 15. SARS-CoV-2 re-infection: a case report from Qatar.
    AlFehaidi A; Ahmad SA; Hamed E
    J Infect; 2021 Mar; 82(3):414-451. PubMed ID: 33115660
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical characteristics and follow-up analysis of 324 discharged COVID-19 patients in Shenzhen during the recovery period.
    Liu HQ; Yuan B; An YW; Chen KJ; Hu Q; Hu XP; Zhao J; Dong Y; Chen YX; Li WX; Sun CQ; Wang JC; Wang C; Song S
    Int J Med Sci; 2021; 18(2):347-355. PubMed ID: 33390803
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical characteristics of re-positive COVID-19 patients in Huangshi, China: A retrospective cohort study.
    Zhou J; Zhang J; Zhou J; Yi H; Lin Z; Liu Y; Zhu M; Wang H; Zhang W; Xu H; Jiang H; Xiang Z; Qu Z; Yang Y; Lu L; Guo S; Fu H; Adcock IM; Wei Y; Yao X
    PLoS One; 2020; 15(11):e0241896. PubMed ID: 33147282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive, again! What to make of "re-positive" SARS-CoV-2 molecular test results.
    Simon V; van Bakel H; Sordillo EM
    EBioMedicine; 2020 Oct; 60():103011. PubMed ID: 32977160
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of vascular risk factor burden on the severity of COVID-19 illness, a retrospective cohort study.
    Du H; Pan X; Liu N; Chen J; Chen X; Werring DJ; Ambler G; Li X; Chen R; Zhang Y; Huang H; Lin F; Xia P; Chen C; Zheng Z; Wu S; Lei H; Gao L; Huang M; Lin K; Xu X; Luo Y; Zhao Z; Li C; Lin H; Lin Y; Huang Z; Cao R; Chen L;
    Respir Res; 2020 Sep; 21(1):241. PubMed ID: 32957997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response.
    Turner JS; Day A; Alsoussi WB; Liu Z; O'Halloran JA; Presti RM; Patterson BK; Whelan SPJ; Ellebedy AH; Mudd PA
    Front Immunol; 2020; 11():618402. PubMed ID: 33488630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.